drugset / Trial / NCT07809854

Evaluating an Innovative Tobacco Treatment Approach for Veterans in Substance Use Treatment

NCT07809854 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Veterans with substance use disorders smoke at extraordinarily high rates and have high rates of smoking-related death and disease. It is essential to provide tobacco treatment for Veterans with substance use disorders, but there are unfortunately low rates of smoking treatment engagement within the VA for those with substance use disorders. The goal of this project is to generate preliminary evidence for a smoking intervention program called "Concurrent Substance and Tobacco Outpatient Program" or Co-STOP. Co-STOP aims to increase tobacco treatment use and effectiveness for Veterans in outpatient substance use treatment. The investigators hypothesize that Co-STOP, relative to standard tobacco treatment, will increase tobacco treatment use and quit attempts. This research will help the VA develop effective strategies to promote smoking treatment use and abstinence in Veterans with substance use disorders who smoke, thereby improving rates of morbidity and mortality in Veterans with substance use disorders.

Timeline

Start
2027-04-01
Primary completion
2030-04-01
Completion
2031-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg Oral
Subject Nicotine Unknown 4 mg Oral
Subject Nicotine Unknown 14 mg Oral
Subject Nicotine Unknown 21 mg Oral

Indications

No indication recorded.